Connection

Jennifer Harcourt to Spike Glycoprotein, Coronavirus

Back to Details
This is a "connection" page, showing publications Jennifer Harcourt has written about Spike Glycoprotein, Coronavirus.
Jennifer Harcourt
Connection Strength
0.031
Spike Glycoprotein, Coronavirus
  1. Shedding of Culturable Virus, Seroconversion, and 6-Month Follow-up Antibody Responses in the First 14 Confirmed Cases of Coronavirus Disease 2019 in the United States. J Infect Dis. 2021 09 01; 224(5):771-776.
    View in: PubMed
    Score: 0.007
  2. Serologic Testing of US Blood Donations to Identify Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Reactive Antibodies: December 2019-January 2020. Clin Infect Dis. 2021 06 15; 72(12):e1004-e1009.
    View in: PubMed
    Score: 0.007
  3. Rapid development of neutralizing and diagnostic SARS-COV-2 mouse monoclonal antibodies. Sci Rep. 2021 05 06; 11(1):9682.
    View in: PubMed
    Score: 0.007
  4. Susceptibility to SARS-CoV-2 of Cell Lines and Substrates Commonly Used to Diagnose and Isolate Influenza and Other Viruses. Emerg Infect Dis. 2021 05; 27(5):1380-1392.
    View in: PubMed
    Score: 0.007
  5. Recombinant protein-based assays for detection of antibodies to severe acute respiratory syndrome coronavirus spike and nucleocapsid proteins. Clin Vaccine Immunol. 2007 Mar; 14(3):331-3.
    View in: PubMed
    Score: 0.002
  6. Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): identification of neutralizing and antibodies reactive to S, N, M and E viral proteins. J Virol Methods. 2005 Sep; 128(1-2):21-8.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.